Characterization and application of two novel monoclonal antibodies against 2IgB7‐H3: expression analysis of 2IgB7‐H3 on dendritic cells and tumor cells

Publisher Website
Google Scholar
Abstract
Abstract:  2IgB7‐H3 has recently been identified as a new member of the B7 family. Its expression at the protein level remains largely unknown due to the lack of the specific monoclonal antibody (mAb). To characterize the expression of 2IgB7‐H3, we newly generated two mouse antihuman 2IgB7‐H3 mAbs (4H7 and 21D4). We found the constitutive expression of 2IgB7‐H3 on a series of tumor cell lines. Furthermore, the expression was examined on monocyte‐derived dendritic cells (Mo‐DCs) and DCs from CD34+ hematopoietic progenitor cells (HPC) by means of mAb staining. The results showed that 2IgB7‐H3 was expressed on Mo‐DCs at a high and stable level during differentiation in vitro. With the maturation of DCs from CD34+ HPCs, the expression of the molecule was upregulated. However, the 2IgB7‐H3 was not expressed on fresh isolated T and B lymphocytes, monocytes, or CD34+ HPCs. These results suggested that 2IgB7‐H3 may be a valuable surface antigen for the detection of DCs.